secwatch / observer
8-K filed January 4, 2024, 6:59 PM ET ticker INBS CIK 0001725430
regulatory confidence high sentiment neutral materiality 0.50

INTELLIGENT BIO SOLUTIONS INC. (INBS): Nasdaq/NYSE listing notice — INBS regains Nasdaq compliance on stockholders' equity, but faces ongoing monitoring

INTELLIGENT BIO SOLUTIONS INC.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INTELLIGENT BIO SOLUTIONS INC. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

Exchange
nasdaq
Notice
compliance regained
Deficiency
stockholders equity
Rules
5550(b)(1)
Exact text from the filing
January 2, 2024, to submit a plan to regain compliance with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1). On December 15, 2023, the Company submitted a compliance plan to Nasdaq that included a pro forma balance sheet as of October 31, 2023 (the “Balance Sheet”). The Balance Sheet showed that the Company’s stockholders’ equity as of October 31, 2023, was $4,240,629, which was primarily the result of the of a public offering of the Company’s securities that closed on October 4, 2023. The Balance Sheet was also attached to a Current Report on Form 8-K filed b
View on SEC.gov

Browse all listing & compliance notices →

INTELLIGENT BIO SOLUTIONS INC. filing history →

Source: SEC EDGAR
accession 0001493152-24-001103
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.